POPULARITY
Categories
Show off your Lone Star spirit with a free "Remember the Alamo" hat with an annual subscription to The Texan: https://thetexan.news/subscribe/Learn more about the Data Center Coalition at: https://www.centerofyourdigitalworld.org/texasThe Texan's Weekly Roundup brings you the latest news in Texas politics, breaking down the top stories of the week with our team of reporters who give you the facts so you can form your own opinion.Enjoy what you hear? Be sure to subscribe and leave a review! Got questions for the reporting team? Email editor@thetexan.news — they just might be answered on a future podcast.Paxton Up 9 Points on Cornyn in 2026 Primary Matchup, Hunt at 15 Percent in Three-Way RaceTexas House Approves Floor Substitute to Bill Abolishing Texas Lottery CommissionTexas House Approves 'New Hollywood' $300 Million Film Tax Incentive Program$2.5 Billion Water Infrastructure Deal, Additional 20-Year Annual $1 Billion Struck in Texas LegislatureTexas Medical Cannabis 'Compassionate Use Program' Expansion Bill Passes SenateSchool Prayer Times and Classroom Ten Commandments Legislation Pass Texas Legislature, Head to Abbott'Making Texas Healthy Again' Nutritional Education, Labeling Bill Advances in HouseBan on Child Sexual Abuse NDAs Passes Texas Legislature, Heads to Governor's DeskCement kilnTexas House Passes Texas Sheriffs-ICE Immigration Enforcement Contract BillFirst ‘Project Homecoming' Flight Voluntarily Deports 64 Illegal Aliens from HoustonBill Adding NRA to Texas Major Events Program Delayed in House After Democratic Oppositionand more!
Summary: In this podcast episode, Rhona Pierce interviews Cynthia Abbot Kerr, founder and CEO of WellPay AI, discussing her journey in the compensation industry, the complexities of pay transparency, and the impact of AI on compensation strategies. Cynthia shares insights on the importance of transparency in pay, the challenges of decision fatigue in compensation, and her transition from HR executive to entrepreneur. The conversation highlights the evolving landscape of compensation and the role of technology in shaping future strategies.Takeaways:TakeawaysHer early career experiences sparked Cynthia's passion for compensation.WellPay AI aims to simplify compensation strategies using technology.Compensation is often misunderstood as an easy process, but it is complex.Pay transparency is becoming essential in modern workplaces.AI can significantly speed up compensation processes and decision-making.The human element in compensation decisions is crucial.Companies need to embrace pay transparency to build trust.Cynthia emphasizes the importance of educating employees about pay structures.Entrepreneurship changes how people perceive and interact with you.Ignoring naysayers can lead to success in business.Chapters:00:00 Introduction to WellPay AI and the Podcast01:53 Cynthia's Journey in Compensation and Technology06:01 The Complexity of Compensation and Pay Transparency12:06 AI's Impact on Compensation Strategies14:58 Transitioning from HR Executive to Entrepreneur18:54 Lessons Learned as a Founder
Korey and Joe sit down with Chelsi Abbot, Scientific Advisor/Education Specialist at the Davey Institute. Chelsi discusses her career as a plant pathologist and how she works to help educate people on plant pathology. Chelsi and the guys also discuss some of the new technology entering the plant pathology industry and what its impact could be down the line. If you enjoyed the podcast please rate, review, subscribe and tell a fellow tree lover! Send your questions or topics you would like us to discuss to info@discoveringforestrypodcast.com.Be sure to follow us on all your favorite social media platforms!Twitter/X: @DisForestryPodInstagram: @discovering_forestryFacebook: Discovering ForestryYouTube: @discoveringforestry6905LinkedIn: Discovering Forestry PodcastMusic credit: Cool Tools Music Video - "Timber" Muzaproduction “Sport Rock Logo 1”Hosted by: Joe Aiken & Korey LofyProduced by: Nico ManganielloArtwork by: Cara Markiewicz & Nico Manganiello
Tony Abbott was on a layover in Dubai when he phoned Natasha Griggs – the president of the Country Liberal Party – and set off a chain reaction inside the Coalition. Hours later, Senator Jacinta Nampijinpa Price defected to the Liberals and a surprise leadership ticket was taking shape. For moderates, it was another sign that the former prime minister and his confidante, Peta Credlin, are still pulling the party’s levers from the outside. Today, national correspondent for The Saturday Paper Jason Koutsoukis, on Tony Abbott, the shadow network steering the Liberals and why insiders say it’s a cancer that’s killing the party. If you enjoy 7am, the best way you can support us is by making a contribution at 7ampodcast.com.au/support. Socials: Stay in touch with us on Instagram Guest: National correspondent for The Saturday Paper, Jason Koutsoukis. Photo: SuppliedSee omnystudio.com/listener for privacy information.
GGACP celebrates the birthday of the legendary “Pit Bull of Comedy” — actor, comic and horror movie aficionado Bobby Slayton (b. May 25) by revisiting this interview from back in 2016. In this episode, Bobby sits down with Gilbert and Frank for a funny and freewheeling discussion of a number of essential topics, including the brilliance of Ray Harryhausen, the tragedy of Bela Lugosi, the haunting of Sammy Davis, Jr. and the greatness of “Abbott and Costello Meet Frankenstein.” Also, Bobby roasts Hal Roach, hangs with Buddy Hackett, breaks bread with Woody Allen and “becomes” Joey Bishop. PLUS: Una O'Connor! “The Adventures of Ford Fairlane”! The return of Rondo Hatton! Bobby meets Otis the Drunk! And the death of Louie Dumbrowski! Learn more about your ad choices. Visit megaphone.fm/adchoices
This episode covers: Cardiology This Week: A concise summary of recent studies The role of cardiac magnetic resonance in myocardial disease Air pollution and heart disease Statistics Made Easy: Quasi-experimental study designs Host: Rick Grobbee Guests: Carlos Aguiar, Steffen Petersen, Mark Miller Want to watch that episode? Go to: https://esc365.escardio.org/event/1806 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Rick Grobbee, Nicolle Kraenkel and Mark Miller have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
Host: Rick Grobbee Guest: Steffen Petersen Want to watch that extended interview? Go to: https://esc365.escardio.org/event/1806?r Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Rick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
Preena: Welcome to the Weinberg in the World Podcast, where we bring stories of interdisciplinary thinking in today's complex world. My name is Preena Shroff and I'm your student host of this special Weinberg in the World episode. I'm a third year student majoring in neuroscience and global health studies with a minor in data center. Today I have the pleasure of speaking with Natasha Phillips, who graduated from Weinberg College in 2000 with a Bachelor of Arts in sociology and biology. Natasha currently serves as chief marketing officer for GE Healthcare, leading teams that help healthcare providers design treatment plans for their patients. Natasha, thank you so much for being here with us today. Natasha: Thanks for having me, Preena. It's a pleasure. Preena: We are so excited to learn about your work in healthcare marketing, but would love to start out with how your career path was shaped by your time at Northwestern. Maybe you can tell us more about your undergraduate experience, what were some impactful classes, extracurriculars, or mentorships opportunities that you had which impacted your post-graduate career? Natasha: Yeah. You're making me think a little bit, because I got to go back in time. As an undergraduate, I was super lucky, having both a biology and a sociology major, it gave me the ability to see a very wide range of classes. I wasn't 100% sure actually what I wanted to do. I knew I was somewhat interested in the sciences. I didn't actually know I would be that interested in the social sciences, but I took a couple of classes. One in particular was the Sociology of Race and Ethnicity with Charlie Moskos, which actually made me decide to ... That was the reason I became a sociology major. I just got super lucky, I loved that class. It's funny, if I ever had a second life, I always say I would have loved to have gone back and been a sociology professor. But I didn't take that path, I went more with the actual biology side of things. I was weighing, do I want to do research? I actually was really interested in molecular biology, primarily because in the late '90s, which is a very long time ago to our students who are listening, but for me that was a time very formative because they were sequencing the human genome. There was a lot of promise in the space, not only of biology, but more specifically molecular biology and how it is linked to genetics and genomics as we think about the impact on healthcare. That really interested me to the point where I really was considering actually getting my PhD in molecular biology. Some of my favorite classes were the ones in which I had exposure to research, because I got to see the importance of just the impact that research can have. And the ability to be able to find a practical application, even if it's on a very specific question, to really contribute to the body of knowledge. Ultimately ended up being unsure what I wanted to do right after undergrad, so I went into healthcare consulting in which I wanted to be able to figure out, do I want to go towards the more business side of healthcare and thinking about commercializing healthcare and science from the industry side of things? Or to the academic side and actually get my PhD, and think about contributing to science and healthcare in that realm. I did have exposure, both in consulting as well as in research. I started in a research program at the University of Chicago in molecular biology after doing consulting so I could see both sides. And ultimately, actually, that was when I made the decision to focus much more so on the business side of it and to get my MBA, and to move into healthcare marketing. That led me into the career in which I've had today, in which I've been very lucky to have over 15 years working at very large multinational healthcare companies, primarily in sales and marketing roles, bringing innovation in healthcare to people all over the globe. Preena: Absolutely. Wow, yeah. I think your path is actually not only a common path that students seek out, but also something that students might end up finding themselves in, even if they do experience a career switch in their life. That's really interesting to hear about. I have another question for you, more specifically job-oriented. Healthcare is constantly evolving, so maybe you can tell us a little bit about how your marketing approach has changed since you began your career? Natasha: Yeah. I love that question, Preena, because what really is happening is healthcare is evolving and the function of marketing is evolving constantly. I am really lucky that, both in the subject matter that I basically have decided to focus in, which is healthcare and ultimately the innovation around healthcare, but also have a really cool and exciting function that continues to evolve. I was lucky enough during my ... Maybe I'll start with the functional part, I'll start with marketing first, and then I'll talk about healthcare. The basic function of marketing has changed significantly over the past 20 years as I've been a marketer, primarily with the advent of digital and social media. It continues now to evolve, as we think about personalized marketing and AI, and what that's going to do. I would say the main changes that I've seen over time has been from a very I would say structured, one size fits all, if you think about it like mass media type of marketing in which there was a time in which you had one singular message and one singular way of approaching individuals, and not a lot of channels to reach them. To now, moving to almost a fully personalized marketing experience, where you have the ability with technology today to be able to say, even if you have thousands of targets, how do you understand the fine differences. There's got to be some generalization amongst those targets, but there's also some fine differences in how people consume their information, care about interacting with your brand, and want to be able to either become loyal brand advocates or detractors. How do you understand what those insights are to create an ongoing personalized journey that evolves over time with the individual as their media consumption and interest in whatever product you're selling changes? That's been one of the coolest innovations to think about, as we think about the function. If I look at healthcare, I've been lucky enough to see innovation across a variety of different segments within healthcare. I'd seen the advent of biologics. If we think about innovation from a healthcare point of view, in basically the last 20 years or so, we've seen drugs like Humira, which started the biologic class and has now exploded into one of the largest categories or segments within healthcare. And the significant impact that that has had on millions of patients, and has changed diseases all the way from skin conditions to much more serious autoimmune type of conditions. I've been lucky enough to see innovation on the diagnostic side, in which I've seen the advent of brand new technologies, including things like multi-plexing. Of taking a single sample, and instead of wanting to get one answer, you can get anywhere from 25 to 30 answers of which virus of which disease somebody has. And the impact that that has had not only on just healthcare, but on infectious disease and vaccines in other parts. For me, what has actually kept me so motivated in healthcare for so long is it isn't just an idea. I get to be part of the teams, and it's a cross-functional team that includes everybody from scientists, research and developers, operations, medical affairs, clinical affairs, marketers, salespeople, finance people, and everybody, I'm sure I'm forgetting some functions. It is such a complex effort to bring innovation like this to market and sometimes can take 10 to 15 years, but when it happens you actually see significant change in healthcare. For me, that's the ability to think even 30, 40 years from now, some of the either diagnostics, devices, or drugs that I've helped to bring to market will really have an impact. Either because it continues to improve healthcare or it was the precursor of future innovation that's going to continue to come because we've paved the way for it, so it's really cool. Preena: Absolutely. That's really incredible. And the way you're able to work with people of many different fields and backgrounds, and then learn from them as well is a really incredible experience, and I hope defines a lot of students' careers in the future as well. Natasha: Yeah. I think just to add to that, the one thing to really keep in mind is I love the interdisciplinary approach that a really good college in arts and sciences like Weinberg does. Because for me, that kind of thinking, although I didn't understand it at the time because I was just a student and I had no clue what I was actually going to do, is something that to this day in my career I think back to and I leverage. It's helped to make me successful, especially in a very large matrix cross-functional organization. It's something that, as all of you who are students potentially listening to this and are thinking, "What might I do in the future?" Really leverage the opportunities that you have to do that kind of interdisciplinary type of work because it will make you much stronger in whatever field you decide to do. Preena: Yeah, absolutely. Going off of that, a bit in the other direction, but what is a common misconception about working in the healthcare marketing industry? Natasha: That is a great question. This is maybe a little controversial, but I'm going to say it. I think there is this perception of big, bad pharma and big, bad healthcare. I think it's something that is an understandable point of view and one which requires probably much more dialogue than what we can answer here. But I'll just leave people with this one thought. Which is if you think about most of the major innovations that have come to healthcare over the last 30 years, whether it's drugs to treat high blood pressure or hypertension, or innovations in diagnostics as I mentioned to be able to not just understand what's happening from blood count, but to be able to look at the molecular and cellular level to treat rare diseases and everything in the middle. Much of that innovation, while it is funded and founded in the basic research that happens at academic and other institutions, has really been driven by the industry. Whether it's the pharmaceutical industry, the med device industry, the diagnostic industry. That requires significant investment and significant time. It also requires a very high failure rate. In some cases, if you have 100 compounds or 100 ideas that you're bringing through, less than 1% of them will sometimes make it to market. There is a significant amount of investment that needs to happen. While there's always optimizations that could happen, I always implore people to think about the fact that the drug that your mother or father is taking today, or that your brother or sister is taking for asthma, didn't exist probably even 20 or 30 years ago because we didn't have the funding and innovation that was coming necessarily maybe from companies that has been pushing that forward. While there is a lot of discussion to be had about healthcare and the rights to healthcare, I think companies like mine, whether it's my current company or previous company, have played a very important role in really helping to improve overall health and healthcare as we think about the impact on people's lives. I just ask people to be open to the fact that there's always a variety of different vantage points and it's always a great healthy dialogue to have. Preena: Of course, yeah. From what you said, it sounds like it's a bit of a trade-off and it's really important to discover where you fit in within that sphere, and learn how to interpret your work and your path in that direction as well. Just realizing what impact you're making and picturing that longterm. Natasha: Yeah, exactly. Preena: Okay. Then, I was also going to ask you about the student perspective, thinking about students today. How would you recommend students cultivate a personal brand? A lot of times people say networking. How do students network authentically, both online and in-person so that they can find the right opportunities or even the right opportunities can find them? Natasha: Yeah, I think it's a really great question. I very much will reiterate the importance of networking because I think that's foundational and fundamental to everything that we do today. In fact, many of you who got into very competitive colleges probably had to figure that out as you were even thinking about how to get into the school that you're in today. That thought process needs to continue as you think about getting your first job, or maybe you're getting your next pre-professional school that you're focused on. I would take that networking to the next step to say I think some of the most effective networking has two really good components. I find this, because I have a lot of people who maybe reach out to me, either through my network or because they're looking for learning about marketing or healthcare, or other topics that maybe I've had some experience with. The first of those two things is really having a genuine brand, and one in which you really own and feel passionate about. The most interesting and coolest networking that I do, even with students today, are the ones in which people are very purposeful about what they are interested in, what they care about, what their brand is. It's probably hard to even think about me as a college student, what is my brand? But you have a brand. You may not know it yet, but you definitely have and can develop a brand. That brand should be whatever you feel truly passionate and genuinely interested in, because that will only I would say help you have much more successful networking and much more genuine connections with the people that you are trying to connect with. Even if that individual maybe doesn't understand or isn't that maybe close to the topic, you'd be shocked how just that genuine authenticity is going to help drive really stronger connections in networking that are going to help both you, as well as the network that you're creating, as you think about the fact that one day you're going to have a network and you're going to want to be able to pay it forward to students the way maybe people are helping you with your decisions and career today. The second one as you think about networking is a lot of times, networking and finding a good fit, whether it's a company or your next pre-professional program, or what you even want to do, is based on having a shared purpose with whoever you're networking with or whatever that institution is. I find the people who come and are most prepared for interviews, in addition to feeling very genuine and knowing what their brand is, are the people who are very clear on what my purpose, either as an institution is, or whatever group I'm part of. They understand that and it is very much akin to who they are, what they're looking for, what makes them passionate. That sense of shared purpose in networking I think is another way in which you can more successfully think about how do you take your decisions or whatever you're going to do next in your career path and be more successful in terms of what you want to do. Then the last thing I would say is don't feel super ... I know everybody's pressured to feel like they know exactly what they want to do and I understand that. I'm sure many of the people who are listening to this are very high performing, have always been very successful in life, have known exactly what they want to do. But there's a lot of benefit to maybe giving yourself the luxury of knowing you have a very long marathon ahead of you, as you think about the decision making in your career choices that you're going to make. If there's ever a time to be open to it, it's probably earlier in your career when you're maybe more willing to not only take some risks, but also be true to what you actually think will be interesting to you over a longterm career. Don't be afraid if it's not going to be a straight line. It might be a really curvy, cool path. At the time, it might feel a little discouraging, but don't be discouraged. Because I would argue, if I look back, some of my coolest decisions were the ones in which it wasn't this straight line, very clear path of what I wanted to do. But rather, I was either more open because of external circumstances or internal motivation to being a little bit more flexible and not so purposeful, and everything must be this in this timeframe. I think if you have some openness to that, it will really help you and probably put a lot less pressure on you as you're thinking about your career. Preena: Right. Yeah, that's really great advice. In terms of winding paths, switching over to your career and more of your day-to-day role, what would say is a challenge or challenges that you often find or encounter in your day-to-day role and how do you approach those? Natasha: That's a good question. My challenges in my day-to-day role. I'm fortunate in which I lead a functional team, so I have the benefit of having an amazing team that I work with every day across a variety of brands and products, across a very diverse portfolio. I've been lucky enough to do that at this current company, which is GE Healthcare, and the previous company I was at which is Abbott. Many times, if I think about the biggest challenges in my day-to-day, it really is around I would say three big areas. The first one is when you are such a large matrix company that is so dependent on your other functional teams, to ensure that you are all very clear on what the goal is, what you're all trying to accomplish, and that you're all rowing in the same direction, and have shared purpose and goals. Often times in our day-to-day, even in companies where you think everybody's on the same team, you can often find that there's actually sometimes a bit of misalignment or competing priorities. Sometimes that's because we're different functions or groups, sometimes it's because we're different segments. Sometimes it's just because we don't understand that shared goal. It's keeping everybody aligned to the mission, strategy, and vision. I would say as marketers actually, I feel like we are big drivers of that in an organization. It's something I always feel very responsible for and want to help my team feel very responsible for. That's the first one. The second one is we work in a very complex landscape. We're highly regulated here in healthcare. We want to do the right thing. Actually, I always tell people I'm so glad that we're highly regulated because the decisions we make actually impact life or death. It's actually for all the right reasons that we have very strict regulatory and approval processes, and then ongoing monitoring of all of our activities from our quality processes to our commercial processes and everything in between. But that can bring a lot of complexity. You've got to navigate a lot of sometimes tough legal and compliance discussions. But at the end of the day, the way we navigate them successfully as a team is really by reminding ourselves that the reason these regulations exist is to keep patients, our own family members who are consuming healthcare every day safe. We're able to do that. I feel we, despite sometimes difficult discussions, always get to the best answer in doing what's right for the patient and what's right for healthcare. Then the third thing, which is I think sometimes hard, is we all come to work every day because we actually care about healthcare and saving lives. That's sometimes really hard to remember when you get stuck in your day-to-day. You can be at a tough meeting, or a really hard strategy review, or a really hard finance review, or maybe you're missing your number in this sales goal. But at the end of the day, those hard days are really worth it because of what ultimately we're bringing to patients all over the globe. Again, there are these challenges, but over a long career I've been able to figure out how to successfully navigate them. So that I feel that even the challenges motivate me to come to work, and figure it out, and be better tomorrow. Better today and tomorrow than I was yesterday and in the past. I try to motivate my teams to think about that in the same way. Preena: Absolutely. Oh, yeah, that was very insightful. I think a lot of these can be applied to any fields, because a lot of times, in healthcare specifically, there is definitely life and death impacts. Then in other fields, people can have those same hard conversations and still need to have that resilience and build up that resilience to come back from that. Natasha: Very true. Very, very true. Probably very similar, just maybe different categories, but very similar discussions that would happen- Preena: Absolutely. Natasha: ... outside of healthcare, too. Preena: Yeah. Okay. Well, thank you very much for sharing this with us and thank you for joining us today. That is all the questions I have. We really value your time, and for coming on and speaking to all of our students. Thank you very much. Natasha: Thank you for having me. It was pleasure to talk to you.
Daily Soap Opera Spoilers by Soap Dirt (GH, Y&R, B&B, and DOOL)
Click to Subscribe: https://bit.ly/Youtube-Subscribe-SoapDirt Young and the Restless 2-week spoilers for May 19-30, 2025 see Nick Newman (Joshua Morrow) finds himself in an increasingly complex situation, with Sally Spectra (Courtney Hope) growing suspicious. Lily Winters (Christel Khalil), Nate Hastings (Sean Dominic), and Devon Hamilton (Bryton James) discussing Amanda Sinclair (Mishael Morgan) representing the enigmatic Aristotle Dumas. Damian Kane (Jermaine Rivers) decides to settle in Genoa City and invites Amy Lewis (Valarie Pettiford) to live with him, creating tension with Devon on the CBS soap opera. Y&R spoilers see Amanda rejects Phyllis Summers' (Michelle Stafford) business proposal, believing her to be unprepared. Phyllis, in turn, suspects Dumas of seeking control over Chancellor, a prospect that excites her given the potential impact on Victor Newman (Eric Braeden) and Nikki Newman (Melody Thomas Scott). Billy Abbott (Jason Thompson) assures Sally that he won't rehire Phyllis, despite his visible introspection over the matter. Spoilers for Young and Restless see Holden Novak (Nathan Owens) interrogating Kyle Abbott (Michael Mealor) about his past with Audra Charles (Zuleyka Silver). Claire Grace Newman (Hayley Erin) proposes an idea to Victor, while Victoria Newman (Amelia Heinle) makes a decision about her relationship with Cole. Diane Jenkins (Susan Walters) worries about feeling like an outsider within the Abbott family, while Michael Baldwin (Christian Jules Leblanc) tries to distract Lauren Fenmore (Tracey Bregman) from their issues. Also, the possible recasting of Kane Ashby as actor Billy Flynn may come the weeks of 5/19-5/30, 2025. Visit our Young and the Restless section of Soap Dirt: https://soapdirt.com/category/young-and-the-restless/ Listen to our Podcasts: https://soapdirt.podbean.com/ Check out our always up-to-date Young and the Restless Spoilers page at: https://soapdirt.com/young-and-the-restless-spoilers/ Check Out our Social Media... Twitter: https://twitter.com/SoapDirtTV Facebook: https://www.facebook.com/SoapDirt Pinterest: https://www.pinterest.com/soapdirt/ TikTok: https://www.tiktok.com/@soapdirt Instagram: https://www.instagram.com/soapdirt/
Avery is a first-year college student who has earned multiple scholarships. She started her scholarship journey when she participated in the Scholarship Summer Camp a few summers ago. This week, Avery shares her tips and suggestions for students on their own scholarship journey. ---------- Start your scholarship journey this summer with the Scholarship Summer Camp. Your student will learn the skills needed for scholarship success by applying for real scholarships, including a $35,000 scholarship capstone project! Every Monday through Thursday, a new, pre-recorded lesson will be released. On Thursday evenings, we will be live (but recorded for future viewing), discussing the week's lessons and taking Q&A. This online program provides both on-demand and live learning opportunities. Best of all your student will apply for real scholarships during the course of the camp! In fact, your student will apply for scholarships offering more than $40,000 in potential winnings! The Scholarship Summer Camp starts June 2, 2025, and runs for 6 weeks. Here's an overview of what will be covered each week: Week 1: The Basics: The tools, documents, and resources you need for scholarship success. Week 2: Your Personal Narrative: Learn how to build your Personal Narrative, a key component for scholarship success. Week 3: Finding The Right Scholarships For You: Learn where to look and how to determine which scholarships are the best ones to apply for. Week 4: Why Do You Deserve To Win This Scholarship? (Apply for a Real Scholarship This Week!) Week 5: Topical Scholarships (Apply for Another Real Scholarship This Week!) Week 6: $35,000 Capstone Scholarship Project! The Scholarship Summer Camp is for high school students in the Classes of 2026, 2027, 2028, and 2029. Click here to register today: https://www.scholarshipgps.com/summercamp ---------- This Week's Featured Scholarships: $2500 What Will Be Your Trademark? Scholarship $1000 Abbott & Fenner Scholarship $2500 How I Make My Community Great Scholarship $2500 Marcus W. Viles Community Growth Scholarship Big Sun Scholarship for Athletes Weekender: $5000 Christian College Scholarship ---------- Subscribe to our free newsletter, Your Daily Scholarship, here: https://nodebtcollege.substack.com/
In this episode, Lisa Abbott, EVP and CHRO at Boston Children's Hospital, shares how she's modernizing HR, from building a strong talent management foundation to creating a more agile and engaging work environment. She also discusses how reimagining the healthcare workforce can help meet future challenges and revitalize interest in the field.
Cleveland Guardians vs. Cincinnati Reds MLB Pick Prediction by Tony T. Guardians at Reds 1:40PM ET—Luis Ortiz will start for Cleveland. Ortiz in eight starts on the season carries an ERA of 4.78 with WHIP of 1.36. The right hander fans 26.1% with 11.2% walks. Ground balls are 42.4% with 1.25 home runs per nine innings. Andrew Abbott is starting for Cincinnati. Abbott made six starts on the season with an ERA of 2.10 with WHIP of 1.07. The left hander has an elite 31.7% K rate with 10% walks. Ground balls sit at 25.7% with 0.90 home runs per nine innings.
Daily Soap Opera Spoilers by Soap Dirt (GH, Y&R, B&B, and DOOL)
Click to Subscribe: https://bit.ly/Youtube-Subscribe-SoapDirt The Young and the Restless spoilers show that Michael Baldwin (Christian Jules Leblanc) and Kyle Abbott (Michael Mealor) find themselves in hot water with the women in their lives, while Billy Abbott (Jason Thompson) struggles to keep promises he may not be able to fulfill. Sally Spectra (Courtney Hope), worries about her future at Abbottcom as Amanda Sinclair (Mishael Morgan) reveals she's now working for a mysterious figure, Duma. Y&R spoilers reveal that Phyllis Summers (Michelle Stafford) plots her next move, hoping to turn the tide in her favor. Devon Hamilton (Bryton James), Lily Winters (Christel Khalil), and Nate Hastings (Sean Dominic) grapple with the news of Amanda's new affiliation. Damian Kane (Jermaine Rivers) makes a significant decision about his future, which could stir things up in Genoa City. More spoilers for Young and The Restless indicate that Victoria Newman (Amelia Heinle) faces a potential turning point in her relationship with Cole, while Audra Charles (Zuleyka Silver) finds herself at odds with Kyle. As the week progresses, Victor Newman, aka "The Mustache" (Eric Braeden), plans a surprise for his wife Nikki Newman (Melody Thomas Scott), and Diane Jenkins (Susan Walters) attempts to find her place among the Abbott family. Visit our Young and the Restless section of Soap Dirt: https://soapdirt.com/category/young-and-the-restless/ Listen to our Podcasts: https://soapdirt.podbean.com/ And Check out our always up-to-date Young and the Restless Spoilers page at: https://soapdirt.com/young-and-the-restless-spoilers/ Check Out our Social Media... Twitter: https://twitter.com/SoapDirtTV Facebook: https://www.facebook.com/SoapDirt Pinterest: https://www.pinterest.com/soapdirt/ TikTok: https://www.tiktok.com/@soapdirt Instagram: https://www.instagram.com/soapdirt/
What if injuries aren't inevitable, but predictable events with upstream warning signs we can actually address? Henry Abbott, award-winning journalist and founder of True Hoop, joins us to discuss his groundbreaking book "Ballistic: The New Science of Injury-Free Athletic Performance" that challenges everything we thought we knew about athletic durability.Abbott shares fascinating insights from his research at P3 (Peak Performance Project), where cutting-edge biomechanics analysis is revolutionizing how athletes train. Most surprisingly, he reveals how mental limitations often precede physical ones. Through a remarkable personal anecdote about holding his breath for over four minutes after minimal instruction, Abbott demonstrates how our brains frequently create barriers our bodies haven't actually reached.For runners specifically, Abbott provides practical wisdom on proper landing mechanics, identifying injury risk factors, and strengthening the often-neglected muscles beneath the knee that create efficient "bouncy" movement. Rather than obsessing over form while running, he suggests building capability through targeted training, then allowing your body to naturally implement improvements.In the Race Report Spotlight, we hear from 11 runners across four countries who completed the London Marathon. They share their experiences with punishing heat and incredible crowd support. They also describe the emotional highs of crossing Tower Bridge and finishing near Buckingham Palace. Their stories capture both the challenge and the magic of completing a World Major Marathon. Whether you're battling recurring injuries, seeking performance improvements, or simply wanting to run with less pain, this episode offers invaluable insights that might just transform your relationship with running. Subscribe now and join our Rise and Run community as we explore the cutting-edge science of injury-free athletic performance.Henry Abbott's LinksBallistic Book @henryabbott.comTrue Hoop WebsitePeak Performance ProjectRise and Run LinksRise and Run Podcast Facebook PageRise and Run Podcast InstagramRise and Run Podcast Website and ShopRise and Run PatreonPassport to RunRunningwithalysha Alysha's Run Coaching (Mention Rise And Run and get $10 off)Send us a textSupport the showRise and Run Podcast is supported by our audience. When you make a purchase through one of our affiliate links, we may earn a commission. As an Amazon Associate we earn from qualifying purchases.Sponsor LinksMagic Bound Travel Stoked Metabolic CoachingRise and Run Podcast Cruise Interest Form with Magic Bound Travel Affiliate LinksRise and Run Amazon Affiliate Web Page Kawaiian Pizza ApparelGoGuarded
The book chronicles the extraordinary life and leadership of Rome's Emperor Julius Caesar, from his early years to his assassination.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
The book chronicles the extraordinary life and leadership of Rome's Emperor Julius Caesar, from his early years to his assassination.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
The book chronicles the extraordinary life and leadership of Rome's Emperor Julius Caesar, from his early years to his assassination.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Escucha el podcast del programa Sobre Ruedas con Harold Abbott a través de Súper 7 FM, en Santo Domingo, República Dominicana correspondiente al jueves 15-mayo-2025.
Jacob Wilson just launched two homers against the Dodgers (2:22)! ... Javier Baez might be back (7:24)! ... What's up with Jeff Hoffman (10:10)? ... Shane Baz ... FOOLED YOU (12:28). ... Kris Bubic vs. Framber Valdez was great (19:17). ... News (24:33): Roki Sasaki is going on the IL. ... Josh Jung is coming around (38:48). ... How do we rank Abbott, Leiter, Soriano and Springs (45:18)? ... Did you notice Kristian Campbell is slowing down, Robbie Ray has turned things around and more (47:09)? ... We wrap up with leftovers, bullpen updates and streamers (1:05:59). Fantasy Baseball Today is available for free on the Audacy app as well as Apple Podcasts, Spotify and wherever else you listen to podcasts. Subscribe to our YouTube channel: youtube.com/FantasyBaseballToday Download and Follow Fantasy Baseball Today on Spotify: https://sptfy.com/QiKv Get awesome Fantasy Baseball Today merch here: http://bit.ly/3y8dUqi Follow FBT on TikTok: https://www.tiktok.com/@fbtpod?_t=8WyMkPdKOJ1&_r=1 Follow our FBT team on Twitter: @FBTPod, @CPTowers @CBSScottWhite, @Roto_Frank Join our Facebook group at https://www.facebook.com/groups/fantasybaseballtoday Sign up for the FBT Newsletter at https://www.cbssports.com/newsletters/fantasy-baseball-today/ For more fantasy baseball coverage from CBS Sports, visit https://www.cbssports.com/fantasy/baseball/ To hear more from the CBS Sports Podcast Network, visit https://www.cbssports.com/podcasts/ You can listen to Fantasy Baseball Today on your smart speakers! Simply say "Alexa, play the latest episode of the Fantasy Baseball Today podcast" or "Hey Google, play the latest episode of the Fantasy Baseball Today podcast." To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
Analizamos sin spoilers la cuarta temporada de Abbott Elementary, la comedia creada por Quinta Brunson que regresa con más risas, evolución de personajes y nuevas dinámicas en el colegio más divertido de Filadelfia. Sinopsis: La cuarta temporada de Colegio Abbott sigue las aventuras de los profesores y el director de la escuela Willard R. Abbott, quienes, a pesar de las dificultades y la falta de recursos, continúan dedicados a la educación de sus estudiantes Learn more about your ad choices. Visit megaphone.fm/adchoices
Escucha el podcast del programa Sobre Ruedas con Harold Abbott a través de Súper 7 FM, en Santo Domingo, República Dominicana correspondiente al miércoles 14-mayo-2025.
Munaf Manji and Griffin Warner break down MLB betting for Tuesday. The guys also give out best bets. he MLB Tuesday Preview & Best Bets podcast hosted by Munaf Manji and Griffin Warner delivers a game-by-game analysis of the 13 MLB matchups scheduled for Tuesday. The show opens with some light NBA draft lottery banter, but the bulk of the discussion is tightly focused on baseball betting strategies, player performance, and team trends, all based on currently available betting lines. In the Brewers versus Guardians game, both hosts express doubts over Quinn Priester's reliability as the Brewers have lost four straight games he's started, providing him minimal run support. Logan Allen's control issues are acknowledged, but the Guardians are still preferred as a slight home favorite. The Twins against the Orioles matchup sees both hosts backing the Twins, riding their eight-game win streak and taking advantage of Kade Povich's continued struggles, especially at home. Munaf suggests taking the Twins team total over due to their potent offense. For the White Sox and Reds, Griffin leans toward the Reds' offense prevailing, noting the White Sox's dreadful 3-17 road record. Abbott's limited innings aren't seen as problematic due to the White Sox's overall weaknesses. In the Cardinals and Phillies clash, Sonny Gray's consistency and St. Louis' bullpen strength make them an appealing underdog, with both hosts preferring an under if the total reaches eight. The Rays versus Blue Jays game highlights the collapse of Tampa Bay's pitching, with Shane Boz's recent blowups making the Blue Jays the favored side, especially with Jose Berrios pitching steadily at home. In the Pirates versus Mets game, both see little hope for the Pirates despite a recent managerial change, with Munaf favoring the Mets run line and team total over, given Kodai Senga's strong stats. For Nationals versus Braves, the consensus is Braves team total over, citing Soroka's vulnerability and the Braves' offensive firepower, though bullpen concerns persist. The Marlins against Cubs matchup leans strongly toward the Cubs, with their superior offense and Ben Brown's solid form giving them a significant edge. The Rockies versus Rangers game reflects both hosts' disdain for the Rockies' 2-17 road record, suggesting Rangers -1.5 and under 8.5 as the play, with the Arlington ballpark playing pitcher-friendly. Royals versus Astros is a more cautious game, with both acknowledging Michael Wacha's solid form and Framber Valdez's unpredictability when a favorite, but Munaf leans Astros at -140. The Angels versus Padres game is flagged as a potential upset, with Dylan Cease expected to regress after his long no-hit bid. Both hosts side with the Angels due to the risky price on the Padres. In the Yankees versus Mariners showdown, Griffin emphasizes Brian Wu's 11-1 home record and favors Mariners as a home underdog while also suggesting the under, citing the ballpark's suppression of runs. Finally, the Diamondbacks versus Giants game is strongly supported by both as a Giants money line play, highlighting Robbie Ray's perfect 8-0 start record for the Giants. Brentt Fott's last strong outing against the Dodgers is considered unsustainable in the pitcher-friendly Oracle Park, especially given the Giants' ability to win division games at home. Best bets for the day are Griffin's pick of Guardians ML at -120 and Munaf's pick of Giants ML at -105. The overall tone reflects skepticism toward big favorites, leaning instead on undervalued home underdogs and carefully selected unders in specific matchups, especially where bullpen and venue factors suppress offense. Learn more about your ad choices. Visit megaphone.fm/adchoices
Munaf Manji and Griffin Warner break down MLB betting for Tuesday. The guys also give out best bets. he MLB Tuesday Preview & Best Bets podcast hosted by Munaf Manji and Griffin Warner delivers a game-by-game analysis of the 13 MLB matchups scheduled for Tuesday. The show opens with some light NBA draft lottery banter, but the bulk of the discussion is tightly focused on baseball betting strategies, player performance, and team trends, all based on currently available betting lines. In the Brewers versus Guardians game, both hosts express doubts over Quinn Priester's reliability as the Brewers have lost four straight games he's started, providing him minimal run support. Logan Allen's control issues are acknowledged, but the Guardians are still preferred as a slight home favorite. The Twins against the Orioles matchup sees both hosts backing the Twins, riding their eight-game win streak and taking advantage of Kade Povich's continued struggles, especially at home. Munaf suggests taking the Twins team total over due to their potent offense. For the White Sox and Reds, Griffin leans toward the Reds' offense prevailing, noting the White Sox's dreadful 3-17 road record. Abbott's limited innings aren't seen as problematic due to the White Sox's overall weaknesses. In the Cardinals and Phillies clash, Sonny Gray's consistency and St. Louis' bullpen strength make them an appealing underdog, with both hosts preferring an under if the total reaches eight. The Rays versus Blue Jays game highlights the collapse of Tampa Bay's pitching, with Shane Boz's recent blowups making the Blue Jays the favored side, especially with Jose Berrios pitching steadily at home. In the Pirates versus Mets game, both see little hope for the Pirates despite a recent managerial change, with Munaf favoring the Mets run line and team total over, given Kodai Senga's strong stats. For Nationals versus Braves, the consensus is Braves team total over, citing Soroka's vulnerability and the Braves' offensive firepower, though bullpen concerns persist. The Marlins against Cubs matchup leans strongly toward the Cubs, with their superior offense and Ben Brown's solid form giving them a significant edge. The Rockies versus Rangers game reflects both hosts' disdain for the Rockies' 2-17 road record, suggesting Rangers -1.5 and under 8.5 as the play, with the Arlington ballpark playing pitcher-friendly. Royals versus Astros is a more cautious game, with both acknowledging Michael Wacha's solid form and Framber Valdez's unpredictability when a favorite, but Munaf leans Astros at -140. The Angels versus Padres game is flagged as a potential upset, with Dylan Cease expected to regress after his long no-hit bid. Both hosts side with the Angels due to the risky price on the Padres. In the Yankees versus Mariners showdown, Griffin emphasizes Brian Wu's 11-1 home record and favors Mariners as a home underdog while also suggesting the under, citing the ballpark's suppression of runs. Finally, the Diamondbacks versus Giants game is strongly supported by both as a Giants money line play, highlighting Robbie Ray's perfect 8-0 start record for the Giants. Brentt Fott's last strong outing against the Dodgers is considered unsustainable in the pitcher-friendly Oracle Park, especially given the Giants' ability to win division games at home. Best bets for the day are Griffin's pick of Guardians ML at -120 and Munaf's pick of Giants ML at -105. The overall tone reflects skepticism toward big favorites, leaning instead on undervalued home underdogs and carefully selected unders in specific matchups, especially where bullpen and venue factors suppress offense. Learn more about your ad choices. Visit megaphone.fm/adchoices
Escucha el podcast del programa Sobre Ruedas con Harold Abbott a través de Súper 7 FM, en Santo Domingo, República Dominicana correspondiente al martes 13-mayo-2025.
Season 18, Episode 12: Why did one of South Africa's best, Kyle Abbott, pack in international cricket at the peak of his powers at age 29 in favour of going full-time as a county cricketer? It's a question the big quick he's been asked many times since 2017 when he arrived at Hampshire, from that point going on to become one of the most consistently excellent players on the circuit. A terrific person to spend an hour with, ahead of another round where he's been at his most dominant. We thank him for his candour and honesty on a whole range of topics. Another top guest. Support the show with a Nerd Pledge at patreon.com/thefinalword Tickets for our Wormsley match, August 18: uk.emma-live.com/WormsleyFinal2025 Subscribe to Wisden and never pay full price for the Almanack again: www.wisdenalmanack.com/subscribe Get your big NordVPN discount: nordvpn.com/tfw Sort out expat finances with Odin Mortgage & Tax: odinmortgage.com/partner/the-final-word Maurice Blackburn Lawyers - fighting for the rights of workers since 1919: mauriceblackburn.com.au Get 10% off Glenn Maxwell's sunnies: t20vision.com/FINALWORD Save more, earn more—up to 4.22% AER (variable). Interest rates are tiered, with the top rate for balances over £1M. Each tiered rate applies to the portion within that range. New members get these rates free for 6 months; after that, your Tide plan's rates apply. For full offer T&Cs visit https://tide.co/savings Claim £100 cash back (on a £5k deposit) at: https://tide.co/offers/tfw Find previous episodes at finalwordcricket.com Title track by Urthboy Learn more about your ad choices. Visit podcastchoices.com/adchoices
Kenya Hairston is a Senior Project Manager, Adjunct Professor, and Doctoral student. Kenya holds a Master's degree from Franklin University as well as Bachelors Degrees from the University of Toledo and The Ohio State University (that's where Keith and Kenya crossed paths). She is currently a 2nd year doctoral student at Franklin University where she is pursuing her Ed.D in instructional design leadership. Kenya has worked at Abbott since 2015 and now calls Dallas, Texas home. Send us a textGot a questions for us? Email us at wolfingdownfoodscience@gmail.comPlease take a minute to help others find our podcast by leaving a rating and comment on your podcasting app!
Escucha el podcast del programa Sobre Ruedas con Harold Abbott a través de Súper 7 FM, en Santo Domingo, República Dominicana correspondiente al lunes 12-mayo-2025.
Cincinnati Reds vs. Houston Astros MLB Pick Prediction by Tony T. Reds at Astros 2:10PM ET—Andrew Abbott will start for Cincinnati. Abbott has five starts in 2025 with an ERA of 2.25 with WHIP of 1.17. The left hander has an elite 31.6% K rate with 12.2% walks. Ground balls sit at 25.5% with 1.13 home runs per nine innings. A FIP of 3.65. Ronel Blanco is starting for Houston. Blanco, in seven starts, deals with an ERA of 4.98 with WHIP of 1.34. The right hander fans 21.9% with 11% walks. Grounders are 32.6% with 1.57 home runs per nine innings.
Texas Republicans this week moved to ban some foreigners from owning land in this state, sparking an emotional and lengthy debate about a crackdown on immigrants that still won't help many GOP lawmakers avoid nasty primary challenges. Plus, Gov. Abbott says his signature school voucher initiative is a huge win for families and a "promise kept" from his campaign. We'll spell out the facts on that. Join the conversation with Scott Braddock, editor of The Quorum Report, and Houston Chronicle political writer Jeremy Wallace. Learn more about your ad choices. Visit megaphone.fm/adchoices
Scott Jones and Henry Abbott explore the importance of outdoor play, the evolution of sports, and the significance of injury prevention in athletics. They share personal anecdotes about their childhood adventures and parenting experiences, emphasizing the need for unstructured play in children's lives. Abbott discusses his journey as a sports writer and his recent work on biomechanics and injury prevention, highlighting the joy of movement and the relationships built through sports. They delve into various aspects of athletic performance, focusing on injury prevention, particularly ACL injuries, and the biomechanics of landing. They discuss the importance of understanding body mechanics, the impact of footwear on performance, and practical coaching tips for athletes. The dialogue emphasizes the need for tailored training methods and the significance of addressing common issues like 'computer back' in today's athletes. They discuss the evolution of running techniques, the significance of ballistic training, and practical drills that can be applied by anyone. The conversation also touches on the concept of Misogi, emphasizing the value of outdoor challenges and creative training methods to engage communities and promote physical fitness. Chapters 00:00 Introduction and Background 03:03 The Joy of Outdoor Adventures 06:02 The Importance of Play in Childhood 08:59 Navigating Parenting and Outdoor Activities 11:59 The Evolution of Sports and Competition 15:08 Injury Prevention and Biomechanics 18:03 The Power of Movement and Joy 21:57 Exploring Athletic Insights 27:15 Understanding ACL Injuries 33:32 The Importance of Landing Mechanics 39:41 Addressing Computer Back Issues 41:02 The Shoe Debate in Athletics 49:53 Injury Insights and Athletic Training 50:12 The Evolution of Running Techniques 51:45 Ballistic Training for Peak Performance 53:41 Practical Drills for Everyone 57:28 Youth Sports and Development 01:01:10 The Concept of Masogi and Outdoor Challenges 01:05:22 Creative Training Methods and Community Engagement
It would be difficult to find a more suited MotoAmerica Chief Medical Officer than Dr. Carl Price. Who better to assist an injured motorcycle racer than a doctor who has been riding and racing motorcycles since his childhood? We got the chance to chat with the personable Dr. Price on this week's episode of Off Track With Carruthers And Bice to talk about the serious side of our sport - injuries and how to treat them. This week's podcast focuses specifically on the new groundbreaking Abbott technology that allows Dr. Price to use a blood test to help assess riders with suspected concussions on-site at all MotoAmerica events.Support the show
Host: Rick Grobbee Guest: Michele Brignole Want to watch that extended interview? Go to: https://esc365.escardio.org/event/1805?r Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Michele Brignole, Diederick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
This episode covers: Cardiology This Week: A concise summary of recent studies Colchicine for secondary prevention An algorithmic approach to the workup of syncope Milestones: CIBIS II Host: Rick Grobbee Guests: Carlos Aguiar, Sanjit Jolly, Michele Brignole Want to watch that episode? Go to: https://esc365.escardio.org/event/1805 Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests: Stephan Achenbach, Michele Brignole, Diederick Grobbee and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Sanjit Jolly has declared to have potential conflicts of interest to report: grant support from Boston Scientific, honorarium from Boston Scientific, Shockwave, Abiomed, SIS, and Teleflex. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
Henry Abbott, former ESPN journalist, basketball expert, and author of the highly anticipated book "Ballistic: The New Science of Injury-Free Athletic Performance," details how advanced biomechanical analysis can help prevent athletic injuries. Abbott explains the significance of movement patterns, particularly how techniques used by elite athletes at the Peak Performance Project (P3) in Santa Barbara can be applied to everyday people. The conversation covers various topics, including plyometrics, the importance of hip stability and mobility, and the potential for new technologies like AI and computer vision to bring these advanced assessments and training techniques to a wider audience. The episode is rich in practical advice for maintaining physical health and mobility through a lifelong commitment to better movement practices.
Canadian PM insults Nitwit Nero to his face. Nitwit Nero is too far gone to even understand. Posse Comitatus is dead now. Martial Law on the Southern Border. MAGAT judge notes an American citizen has been deported, then sweetly licks Daddy's boot. Mmmmm, boot! Secretary HotMama gets grilled-n-schooled on Capitol Hill. Workers lose NIOSH protection. Anyone who doesn't speak English loses tornado warnings. Head-ON with Roxanne Kincaid – May 6, 2025 Roxanne broadcasts live from WV with signature wit and fury. She covers everything from her upcoming CT scan travel plans to a sweeping critique of the current U.S. administration—mocking "Nitwit Nero" and railing against threats to democracy, human rights, and safety. Topics include: Canada's PM Mark Carney rejecting U.S. annexation talk, calling out the President's delusions. Real ID's creepy rollout and the erosion of constitutional travel rights. DHS stonewalling on due process and deporting a U.S.-born toddler to Honduras. MAGAT-appointed judges and unconstitutional fund withholding by the executive branch. Translation cuts at the National Weather Service leaving immigrant families vulnerable. Layoffs gutting NIOSH and halting worker safety certifications. New military zones at the border and migrant deaths rising in El Paso. Speculation on a third term via a 22nd Amendment loophole. Escalating India-Pakistan tensions and the U.S.'s waning global credibility. A blue wave in Texas local elections rejecting MAGAT extremists. Shocking prison deaths at Marcy Correctional and rare guard convictions. Sharp critiques of Abbott, Rand Paul, Mitch McConnell, and Trump's mental decline. Plus: movie recs, listener banter, glue jokes, and Vatican conspiracies. Password: carney. New call-in #: 844-THE-HORN. Show airs Mon–Fri, 5–8 PM EDT. Roxanne needs ~$700 to meet May's goal—support matters. https://www.headon.live/contribute/
In this conversation, Henry Abbott, founder of True Hoop and author of 'Ballistic', discusses the science of injury prevention in sports, emphasizing the importance of understanding movement mechanics and the role of play in maintaining a healthy relationship with physical activity. He shares insights from his collaboration with P3, a cutting-edge performance center, and highlights the need for athletes to focus on explosive movements and daily maintenance to prevent injuries. Abbott also critiques conventional training methods and the reliance on radiology, surgery, and pharmaceuticals in addressing athletic injuries.Chapters00:00 Introduction to Henry Abbott and His Work03:06 The Connection with P3 and Injury Concerns06:01 The Assessment Process at P309:04 The Importance of Movement and Play12:11 Explosive Movements and Injury Prevention14:52 Understanding ACL Injuries17:57 Zion Williamson: Power vs. Physical Breakdown23:39 The Superhuman Illusion: Zion's Early Success24:40 Revisiting Training Methods: The Shift in Approach25:42 Grooving New Habits: Personal Experiences in Movement30:43 The Three Horsemen of Athletic Apocalypse36:34 The Importance of Hip Mobility and Stability41:09 Connecting with Henry Abbott: The Journey Ahead
It's Monday, May 5th, A.D. 2025. This is The Worldview in 5 Minutes heard on 125 radio stations and at www.TheWorldview.com. I'm Adam McManus. (Adam@TheWorldview.com) By Adam McManus 18-wheeler truck plowed in Easter parade, killing 6, injuring 18 A government-appointed committee determined that the Muslim driver of an 18-wheeler truck that plowed into an Easter parade on Sunday, April 21, in the town of Billiri in Gombe State, Nigeria, intentionally struck the Christians as they celebrated Christ's resurrection. The committee also found that of the 36 people struck in the attack, six died, and 18 remain in critical condition, reports International Christian Concern. Pray Psalm 147:6. It says, “The Lord sustains the humble, but casts the wicked to the ground.” China official hints he wants to end tariff war with U.S. China is hinting that it could be willing to talk to Trump administration officials as a way to end the trade and tariff war, reports The Western Journal. A Chinese Commerce Ministry representative said, “China is currently evaluating” messages from administration officials that “expressed their willingness to negotiate with China on tariffs,” according to the Wall Street Journal. He added, “China's position is consistent. If you want to fight, we will fight to the end; if you want to talk, our door is wide open.” President Donald Trump's 145 percent tariff on Chinese imports led China to impose a 125 percent tariff on American imports. Trump has said he will not blink without concessions that could include greater access to Chinese markets. Chinese-American expert: Get tougher on China Appearing on ‘Fox Report' with Jon Scott, Gatestone Institute senior fellow Gordon Chang explained that China has no tariffs on certain categories of products that only America can provide. SCOTT: “China is making allowances for some US products to be imported without tariffs. Does that suggest that they are finding that it's not so easy to block U.S. products?” CHANG: “Oh, absolutely. And you know, it's not just that they're reducing tariffs. You know, for instance, President Trump reduced tariffs on electronic goods coming in from China. “What China has done, which we learned from both the Reuters and the Financial Times reporting yesterday, is that there are no tariffs on certain categories of U.S goods. So, for instance, aviation parts, semiconductors, medical devices, medicines, industrial chemicals -- things that China can't get elsewhere -- and they're just coming into China tariff-free.” Chang urged Trump to get even tougher on China. CHANG: “Instead of talking about reducing tariffs, I think that we need to start actually imposing some more costs. “So, for instance, China is not taking Boeing aircraft deliveries. We flew back three 737 Maxes from China that were about to be delivered. Well, if I were President Trump, I would say to Boeing, ‘You can no longer provide services or parts to Chinese Airlines because that will ground the Chinese fleet. And I think that will bring the Chinese to heel fairly quickly. “But we need to do some things that would be considered unthinkable. This is not the type of normal trade war that people are used to. This is looking like an all-encompassing struggle. When President Trump last week signaled conciliatory moves, the Chinese even got worse, and they were saying, ‘Well, no talks until the U.S. removes all tariffs.'” Angry parent blasts school board over daughter's gender transition A furious Lakewood, Colorado father, Dustin Gonzalez, lost his temper with woke educators during a county school board meeting, saying his daughter's new gender identity and transition was kept secret from him and affirmed by school staff. GONZALEZ: “I'm not a politician. I'm not a loud voice on social media. I'm a father, a quiet one, one who goes to work, tries to do right by his family, and stays out of the spotlight. But now, now you're gonna remember my name. “My daughter changed her identity, not after years of discussion or family dialogue, not from joint input from both of her parents. No, this happened quickly, secretly, encouraged by a school-appointed therapist in a system that never thought to include me. And the school didn't inform me. They didn't include me. They didn't even ask me. They replaced me! “By the time I found out, I was already labeled ‘the problem.' My objections weren't treated as concerns. They were treated as opposition. My voice was dismissed as hateful. My presence undermined. The therapist, the school, and eventually the court-appointed investigator all decided that because I wouldn't affirm something, I didn't deserve to parent my daughter equally anymore. “They didn't accuse me of abuse. They didn't claim I'd caused harm. The only evidence against me was that I said, ‘I'm not ready to affirm this yet.' That's it! “And now I'm at risk of losing parenting time, of being erased from my daughter's life, not because I failed as a father, but because I dared to ask questions. And it started in your schools. Your systems made it possible, and your silence made it permanent! “You gave my ex all the tools she needed to take our daughter from me, tools that she couldn't have forged on her own. You gave her the therapist, you gave her the ideological support, and you never once thought, ‘Shouldn't the father be involved too?' “You gave her a system that cut me out of the picture. You handed her the tools to eliminate me from my daughter's life. And with your help, she's trying to race me all together. You replaced my voice. You stole my seat at the table. And you made decisions about my daughter without me! “I don't care if you personally signed the policies, stayed silent while he passed, or simply chose not to know, you are all responsible. Don't think you can take a man's child from him and not reap a whirlwind!” Just like Psalm 103:13 articulates, a father has compassion on his child. But sadly, in this case, the government school's woke policies became a wedge between father and child. Texas Governor signs $1 billion school choice program And finally, on Saturday, Texas Republican Governor Greg Abbott signed a $1 billion school voucher program into law, cementing the biggest legislative victory of his decade in office, reports the San Antonio Express-News. ABBOTT: “It is time that we put our children on a pathway to having the number one ranked education system in the United States of America. (applause) “Gone are the days that families are limited to only the school assigned by government. The day has arrived that empowers parents to choose the school that's best for their child.” Abbott referenced parents in the crowd who had already pulled their students from “low-performing” public schools to put them into private ones. Under the $1 billion school choice law, Texas students who are enrolled into the program will receive $10,000 per year to go to an accredited private school. Disabled students will get up to $30,000 per year and home schooled students will receive $2,000 per year per child. The first year of operation will begin in 2027. The state will choose nonprofits to run the program, develop the application process, and pick which 100,000 students will have access to it. Close And that's The Worldview on this Monday, May 5th, in the year of our Lord 2025. Subscribe for free by Amazon Music or by iTunes or email to our unique Christian newscast at www.TheWorldview.com. Or get the Generations app through Google Play or The App Store. I'm Adam McManus (Adam@TheWorldview.com). Seize the day for Jesus Christ.
Brady is back for a rare Monday edition of the podcast, putting the episode out a day early! He talks about the Mariners taking two of three from the Texas Rangers and his potential favorite inning of the season from Saturday's win.Also, what did we see from Matt Brash in his return, and are we surprised by the M's usage of him in his first game back? Also, George Kirby and Logan Gilbert make progress in their returns from injuries. Could we see them back before the end of May as Jerry Dipoto hopes?And former M's pitcher Paul Abbott, who went 17-4 for the team in 2001, stops by for a great conversation about his career, his M's tenure and his work as a minor league pitching coach.We'll be back on Thursday for our weekly chat with Buster Olney of ESPN!
We’re kicking off a brand new series this weekend called "I Needed to Hear That." Each week, we’ll unpack messages that speak directly to real-life struggles, doubts, and hopes—truths we didn’t even know we needed until we heard them. Join us for the livestream and be reminded: you’re not alone, and God is still speaking.
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: A new Austrailian study aims to prevent type 1, the new twiist pump will integrate with Eversnse CGM as well as Libre, diabetes deaths are down in the US, Dexcom U is looking for college athletes, and more! Find out more about Moms' Night Out Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX A world-first human trial of a drug designed to treat the underlying cause of type 1 diabetes has begun in Australia. University of Queensland researcher Ranjeny Thomas said the experimental drug — dubbed ASITI-201 — was designed to retrain the immune system so it no longer attacks the insulin-producing pancreatic cells, known as beta cells. The drug, given as an injection under the skin, combines fragments of a protein found in the beta cells of people with type 1 diabetes and vitamin D to calm the immune response. She said if effective, the drug would initially be given to patients with type 1 diabetes as soon as possible after diagnosis to preserve remaining pancreatic cells and reduce the amount of insulin needed. But eventually, if screening programs can be developed to pick up people at risk of developing type 1 diabetes, it may be possible to "prevent the progression of the disease altogether". The first in-human trial of 36 participants will test the safety of the drug, but blood tests will also determine the impact of the therapy on a patient's immune system and glucose tolerance. https://www.abc.net.au/news/2025-04-29/type-1-diabetes-drug-trial-auto-immune-disease-science/105223022 XX Diabetes deaths in the U.S. have fallen to some of the lowest rates in years, according to new preliminary figures published by the Centers for Disease Control and Prevention, reversing a surge in mortality that was seen during the COVID-19 pandemic. There were 26.4 deaths per 100,000 people from diabetes, according to early death certificate data for the third quarter of 2024 published this month by the CDC's National Center for Health Statistics. Death rates from diabetes peaked in 2021, according to CDC figures, at 31.1 deaths per 100,000 people for that year. Diabetes was the eighth leading cause of death in 2021. The CDC says the link between COVID-19 and diabetes may be to blame for that increase. "Data show an increase in mortality rates for all people during the COVID-19 pandemic, and research shows that people with underlying conditions, including diabetes, are more likely to become very sick from COVID-19 and have a higher risk of hospitalization and death," Christopher Holliday, head of the CDC's Division of Diabetes Translation, told CBS News in a statement. Holliday added that research shows the pandemic may also have made it harder for Americans to properly manage the disease, ranging from interruptions to physical activity to disruptions to routine medical care diagnosing and treating the disease. https://www.cbsnews.com/news/diabetes-deaths-lowest-levels-years-early-cdc-figures/ XX Big news for the Eversense CGM – they have their first pump partner. Sequel Med Tech says the twist pump will integrate with Senseonics Eversense 365 continuous glucose monitor (CGM). This collaboration would make twiist the first AID system compatible with Eversense 365, the world's first and only one-year CGM. Sequel and Senseonics say they have already started their work to integrate the latest-generation, 365-day implantable sensor with twiist. They expect to make the integrated offering available in the third quarter of this year. This marks the second CGM integration for Sequel, which partnered with Abbott and its FreeStyle Libre platform earlier this year. This week we also got a peek at the packaging and delivery of the twist as the first people posted about wearing it. We'll follow up and learn more about this newest insulin pump in the us. Senseonics, meanwhile, brought the first year-long CGM to market last year, launching Eversense 365 with its global distribution partner, Ascensia Diabetes Care, in October 2024. The system also received clearance as an integrated CGM (iCGM) system, meaning it can work with compatible medical devices. Those include insulin pumps as part of automated insulin delivery systems. https://www.drugdeliverybusiness.com/sequel-senseonics-integrate-cgm-insulin-pump/ XX Medtronic has announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync sensor for use with the MiniMed 780G system. With this approval, the MiniMed 780G system now offers more flexibility for users of the company's most advanced insulin delivery system featuring Meal Detection technology with both the Guardian 4 sensor and Simplera Sync sensor. The Simplera Sync is a disposable, all-in-one sensor that requires no fingersticks with SmartGuard or overtape and features a simple, two-step insertion process. It is the company's newest addition to its CGM portfolio, which expands options and provides greater flexibility for users. The MiniMed 780G system's adaptive algorithm automatically anticipates, adjusts, and corrects glucose levels every 5 minutes, 24/7 – working around the clock so users can focus on what matters. It's the only system featuring Meal Detection technology, which detects rising sugar levels and delivers more insulin as needed to help users keep glucose levels in range more often – even when users occasionally forget to dose insulin for snacks or meals or underestimate their carbs. The system uses a “treat to target” approach and flexible glucose targets as low as 100 mg/dL, which, combined with its adaptive algorithm allows it to more closely mirror the glucose levels of someone not living with diabetes. Real-world data of the system shows global users consistently achieve time in range above international targets of 70% when using optimal settings (active insulin time of two hours and 100 mg/dL target glucose). It is also the only system that works with the world's only infusion set that lasts up to 7 days so that users only have to change their infusion set once per week and can experience 96% fewer injections compared to multiple daily injections. “We're committed to driving innovation that makes life easier for those living with diabetes so they can forget about their diabetes as much as possible throughout the day,” said Que Dallara, EVP and president of Medtronic Diabetes. “Our MiniMed 780G system delivers advanced diabetes technology for so many around the world, and we're excited to continue evolving this experience with expanded CGM options —including our Simplera Sync sensor, which we look forward to bringing to people living with diabetes in the U.S.” A limited launch of the Simplera Sync sensor will begin in the U.S. in the fall of 2025. Today, the MiniMed 780G system can be used with the Guardian 4 sensor. Like this:https://med-techinsights.com/2025/04/29/simplera-sync-sensor-for-minimed-780g-now-fda-approved/ XX Front office changes at Insulet.. The former head of Johnson & Johnson's worldwide medtech business, Ashley McEvoy will take over as president and CEO from Jim Hollingshead, who has led Insulet since 2022. In its announcement of the leadership change, Insulet said that Hollingshead and the company mutually agreed to part ways, effective immediately. McEvoy served as worldwide medtech chairman at J&J from 2018 until her departure in late 2023, the culmination of nearly 30 years at the company and several executive roles—including president of its Ethicon division and group chairman of vision and diabetes care. Since then, she has also served as a board member at Procter & Gamble. https://www.fiercebiotech.com/medtech/insulet-taps-former-jj-medtech-head-ashley-mcevoy-be-ceo XX New free mobile game launched this week to make type 1 diabetes onboarding faster easier and less overwhelming. It's called Level One.. created by Level Ex (Powered by Relevate Health), the studio behind award-winning medical games for medical professionals. Level Ex CEO Sam Glassenberg created the game after a – quote - brutal onboarding experience when his daughter was diagnosed five years ago He says It took a year to understand how to manage this disease. So we fixed it. We built a game that can train your brain to do it in a matter of hours." The game is launching in partnership with leading diabetes organizations Beyond Type 1 and Breakthrough T1D Play, who are integrating Level One into their outreach and educational campaigns to support newly diagnosed families worldwide. Download Level One on the App Store: https://apps.apple.com/us/app/level-one-a-diabetes-game/id6739605694 Learn more: https://playlevelone.com https://www.prnewswire.com/news-releases/level-ex-launches-level-one-a-free-mobile-game-to-redefine-type-1-diabetes-onboarding-302440929.html XX Collagen is widely recognized for its role in maintaining healthy skin, but its importance extends far beyond that. As the most abundant protein in the human body, collagen provides essential structure and support to nearly all tissues and organs. Now, researchers at Carnegie Mellon's Feinberg Lab have made a major breakthrough using their novel Freeform Reversible Embedding of Suspended Hydrogels (FRESH) 3D bioprinting technique. This method enables the precise printing of soft, living cells and tissues. Leveraging this technology, the team successfully created the first-ever microphysiologic system, also known as a tissue model, constructed entirely from collagen. This advancement opens new possibilities for studying disease and engineering tissue therapies, including potential treatments for conditions like Type 1 diabetes. Traditionally, small-scale models of human tissue, referred to as microfluidics, organ-on-chip devices, or microphysiologic systems, have been fabricated using synthetic materials such as silicone rubber or plastics. These materials were necessary due to limitations in earlier manufacturing techniques. However, because they are not biologically native, they fail to fully replicate natural tissue environments, restricting their effectiveness in biomedical research and therapeutic development. “Now, we can build microfluidic systems in the Petri dish entirely out of collagen, cells, and other proteins, with unprecedented structural resolution and fidelity,” explained Adam Feinberg, a professor of biomedical engineering and materials science & engineering at Carnegie Mellon University. “Most importantly, these models are fully biologic, which means cells function better.” Building Complex Tissues with FRESH Bioprinting In new research published in Science Advances, the group demonstrates the use of this FRESH bioprinting advancement, building more complex vascularized tissues out of fully biologic materials, to create a pancreatic-like tissue that could potentially be used in the future to treat Type 1 diabetes. This advancement in FRESH bioprinting builds on the team's earlier work published in Science, by improving the resolution and quality to create fluidic channels that are like blood vessels down to about 100-micron diameter. “There were several key technical developments to the FRESH printing technology that enabled this work,” described Daniel Shiwarski, assistant professor of bioengineering at the University of Pittsburgh and prior postdoctoral fellow in the Feinberg lab. “By implementing a single-step bioprinting fabrication process, we manufactured collagen-based perfusable CHIPS in a wide range of designs that exceed the resolution and printed fidelity of any other known bioprinting approach to date. Further, when combined with multi-material 3D bioprinting of ECM proteins, growth factors, and cell-laden bioinks and integration into a custom bioreactor platform, we were able to create a centimeter-scale pancreatic-like tissue construct capable of producing glucose-stimulated insulin release exceeding current organoid based approaches.” https://scitechdaily.com/scientists-bioprint-living-tissues-that-could-revolutionize-diabetes-treatment/ XX Another study showing the blood sugar benefit of walking after a meal. Skeletal muscle plays a central role in glucose uptake. Exercise stimulates glucose transport into muscle cells through insulin-independent pathways, notably through the action of glucose transporter type 4 (GLUT-4), which is responsible for transporting glucose from blood to skeletal muscles.4 This means that even without a robust insulin response, physical activity can facilitate glucose clearance from the bloodstream. These effects also occur without requiring high-intensity exercise, making postprandial walking accessible to a broad range of individuals, including those with limited exercise tolerance. multiple studies show that starting activity within 30 minutes after a meal is optimal. https://www.news-medical.net/health/Walking-After-Meals-Small-Habit-Big-Metabolic-Gains.aspx XX Dexcom brings back Dexcom U for a 4th years. This is a name, image and license program for college athletes with diabetes and includes a nationwide open call for passionate and inspiring college athletes to join its roster. Now through May 23, athletes, coaches, friends and family members can nominate candidates through an online submission. Those selected, along with the eight returning athletes from last year, will be invited to attend the Dexcom U Signing Day Camp this summer, hosted by Dexcom Warrior and Baltimore Ravens tight end Mark Andrews. https://www.hmenews.com/article/dexcom-u-returns-for-fourth-season
Hiring your first employee is a major milestone in your contracting business—and one that often comes with a lot of questions and hesitation. In this episode, Tom sits down with Battleground coach and remodelling business owner Anthony Abbott to talk through the ins and outs of bringing on your first team member. From knowing when it's the right time to hire, to setting expectations, training, and finding the right fit, this conversation is packed with hard-earned wisdom and practical advice.In this episode, they discuss:[00:00] – Why contractors struggle with knowing when and how to hire[00:32] – Introduction to Anthony Abbott, his role in The Fight, and his business growth story[02:20] – The real secret behind Anthony's rapid success: hiring the right people[03:45] – How to know it's time to hire your first employee[04:49] – The importance of finding someone who is adaptable and a culture fit[06:44] – Interviewing for character over competency and spotting growth potential[08:55] – Setting clear expectations to avoid misalignment as your business grows[10:50] – Hiring subcontractors vs. full-time employees—key differences and tips[12:36] – Training your team to handle responsibilities effectively[13:33] – Why hiring slowly can save you major headaches[14:54] – Choosing the right first hire: admin or project manager?[16:02] – The power of delegation: how Tom's team structure freed up his time[16:54] – Breaking through the head trash of “people are the problem”[17:59] – How better leadership could have changed Anthony's early hiring experiences[18:48] – The financial side: viewing employees as investments, not expenses[20:20] – Real numbers: Anthony's explosive revenue growth tied to strategic hiring[21:32] – “I need more money before I can hire”—busting this common myth[22:45] – Battleground: how it helps overwhelmed contractors regain time and control[23:09] – Where to connect with Anthony online and get more hiring insightsLinks from the episode:Connect with Anthony Abbott on Facebook: Anthony AbbottFollow Anthony on Instagram: @theironsharpenerResources:=================================
Corey Abbott and Joe Lynch discuss tech-driven drayage: a PortPro perspective. Corey is the Chief Growth Officer and his team lead enterprise initiatives at PortPro, an innovative technology company that keeps the drayage industry moving efficiently with its operating platform built for drayage trucking companies, brokerages, and those that do both. About Corey Abbott Corey Abbott, Chief Growth Officer and his team lead enterprise initiatives at PortPro, focusing on developing comprehensive products designed to enhance the customer experience, guided by their needs and feedback. Corey spent over a decade at STG Logistics, the nation's leader in containerized freight, and XPO Logistics, where he built operational, financial, and back-office solutions to help companies and users across the globe. He also partnered with companies across multiple industries and modes of transportation (OTR, Drayage, Intermodal, Global forwarding, LTL, Supply Chain Warehousing/ Transloading, Expedited Air, Road, and Water). He held roles of CIO, Intermodal, and Drayage, and most recently, Chief Product Officer. He holds a Master's degree in accounting and finance from the University of North Carolina at Charlotte. About PortPro PortPro is an innovative technology company that keeps the drayage industry moving efficiently with its operating platform built for drayage trucking companies, brokerages, and those that do both. Its flagship TMS platform streamlines order entry, dispatch management, container tracking, communication, appointment-setting, accounts receivable, accounts payable, reporting, AI-driven features, and more for our customers - who can then provide full transparency and better service to their customers. Visit www.portpro.io for more information and to schedule a demo. Key Takeaways: Tech-Driven Drayage: A PortPro Perspective Corey Abbott and Joe Lynch discuss tech-driven drayage: a PortPro perspective. Corey is the Chief Growth Officer and his team lead enterprise initiatives at PortPro, an innovative technology company that keeps the drayage industry moving efficiently with its operating platform built for drayage trucking companies, brokerages, and those that do both. Drayage carriers and brokers face the following challenges: Operational Inefficiencies & Lack of Real-Time Visibility: Difficulty managing complex drayage processes and tracking critical information (containers, status, appointments) leads to wasted time, errors, and increased costs. Manual Processes & Poor Communication Hindering Productivity: Reliance on outdated methods for order entry, scheduling, invoicing, and communication creates administrative burdens, slows down operations, and limits collaboration. Stuck with Outdated Tech or Ill-Suited Systems: Drayage carriers and brokers often face a dilemma: either wrestle with legacy TMS platforms that hinder integration and lack modern AI, or try to force-fit traditional TMS solutions missing crucial drayage-specific features like appointment management. Missing the Mark on Drayage Needs: Existing TMS options frequently fail to address the unique complexities of drayage, lacking the specialized fields and functionalities required for efficient appointment scheduling, container tracking, and overall drayage operation PortPro customers enjoy the following advantages: DrayOS: A Purpose-Built Operating System for Drayage: PortPro's flagship product, DrayOS, is a cloud-based TMS (Transportation Management System) built specifically for drayage operations. It streamlines everything from dispatching and invoicing to document management and container tracking, offering users a centralized platform that eliminates manual workflows and siloed systems. Automated Workflows and Real-Time Visibility: With features like EDI/API integrations, automated billing, and GPS-based container tracking, PortPro empowers carriers and brokerages with real-time operational visibility and faster decision-making. This reduces delays, improves on-time performance, and boosts overall efficiency — critical in an industry where time is money. Compliance and Scalability at the Core: PortPro's technology is designed to adapt to regulatory complexities like AB5 and environmental compliance laws. It helps companies stay ahead of legal changes while scaling their operations without needing to invest heavily in back-office expansion. This makes it especially valuable for mid-sized drayage companies aiming to grow. Specialized AI Agents & Optimizers: PortPro launches AI-powered tools integrated directly into their TMS, offering targeted automation for specific drayage workflows like spreadsheet updates and empty container returns, accessible via an AI Marketplace and customizable chat interface. Key AI Features for Efficiency: The initial rollout includes "AI Chat" for real-time data queries, "Spreadsheet AI Agents" for automatic data synchronization with Excel and Google Sheets, and "Empty Return Agents" to automate the often cumbersome process of managing empty container returns. Addressing Drayage's Manual Inefficiencies: These AI innovations directly tackle the significant administrative burdens in drayage, which can account for up to 20% of operating costs, freeing up operations teams to focus on more strategic and customer-centric activities. Learn More About Tech-Driven Drayage: A PortPro Perspective Corey Abbott | Linkedin PortPro | Linkedin PortPro PortPro's Informative Blogs Case Studies Latest news about PortPro PortPro's Complementary Carrier Guide to Growth State of Drayage Industry Report The Logistics of Logistics Podcast If you enjoy the podcast, please leave a positive review, subscribe, and share it with your friends and colleagues. The Logistics of Logistics Podcast: Google, Apple, Castbox, Spotify, Stitcher, PlayerFM, Tunein, Podbean, Owltail, Libsyn, Overcast Check out The Logistics of Logistics on Youtube
We're picking up where we left off with the Abbott brothers, the two farm boys from Vermont who went on to achieve high levels of success in two different parts of the dairy business: Tim Abbott and David Abbott.We talk about tough decisions, taking risks and what it takes to be successful as a leader. Dave reflects on his experiences as CEO at Purina Mills, as well as stepping outside of the agriculture industry and into various other leadership roles, and Tim talks about taking the leap from corporate to entrepreneurship in dairy cattle breeding with St. Jacobs, and now, Showbox Sires.There's more than 130 years combined of wisdom and lives well-lived in this episode of the Uplevel Dairy Podcast.This Episode is Brought to you by AdisseoThis episode is sponsored by Uplevel Dairy Podcast Founding Partner Adisseo, a global leader in nutritional solutions and premier provider of rumen-protected methionine for dairy producers who want to optimize milk production, capture more value from components, and maintain the health of their high-performing herds. Learn more at https://www.adisseo.com/en/
On episode 1160 of Daytime Confidential, Luke Kerr, Jillian Bowe, Joshua Baldwin and Melodie AIkels dish the latest Beyond the Gates, The Bold and the Beautiful, Days of Our Lives, General Hospital and The Young and the Restless headlines and storylines, including: Kat uncovers Leslie and Eva's connection on Beyond the Gates. Doug seeks help as Joey moves in on his wife Vanessa. The Dupree women sign karaoke. The Forrester Creations fashion show is the backdrop for Brooke vs. Taylor. What illness does Liam actually have? The fallout from Philip cheating Xander out of his birthright continues on Days of Our Lives. Maggie bids big at charity auction to save hosptial. Lulu is being messy on General Hospital and BLQ is confronting her about it. Molly finds the commitmenet papers Alexis had drawn up to commit Kristina. You know it's a slow week when the most exciting thing on The Young and the Restless is the Abbott manion "refresh" reveal. All this and more on the latest Daytime Confidential podcast! Bluesky: @DCConfidential, LukeKerr, JillianBowe, Josh Baldwin, and Melodie Aikels. Facebook: Daytime Confidential Subscribe to Daytime Confidential on iTunes, Google Play, and Spotify.
The news of Texas covered today includes:Our Lone Star story of the day: Lieutenant Governor Dan Patrick points out that the Texas Senate has pass all top 40 “priority bills.” The Senate has, as of Friday, passed 631 bills while the BurrowCrat House has passed only 182. Both officially began work on the same day but as usual the House plays around with its internal politics for months before getting to the work it must do in the 140-day session.And speaking of convening for legislative work, Senator Birdwell has gotten a bill out of the Senate to the House that allows the Legislature to come back into session after the deadline for the governor to veto bills for the purpose of overriding vetoes.Our Lone Star story of the day is sponsored by Allied Compliance Services providing the best service in DOT, business and personal drug and alcohol testing since 1995.More evidence of how much legitimate bail reform is needed, a job the Texas House has failed on in the past: Harris County Magistrates Awarded More than 10,000 PR Bonds for Felonies in 2024.Governor Abbott goes after the City of San Marcos and its anti-Israel resolution.Abbott and Nimm appointed by President Trump to the new FEMA Review Council.Listen on the radio, or station stream, at 5pm Central. Click for our radio and streaming affiliates.www.PrattonTexas.com
Babies, it's Allen's birthday! Or at least it was about a month ago because we all mess up sometimes. Anyway, please enjoy his pick, the 1948 Universal classic "Abbott and Costello Meet Frankenstein." This may be our first Bela Lugosi (correct me if I'm wrong!) but it's definitely not our first Universal classic. Check out Episode 94- "The Bride of Frankenstein," Episode 135- "Creature from the Black Lagoon," Episode 148- "The Wolf Man," and Episode 207- "The Mummy." The regular lineup of links! You can support us at patreon.com/werewolfambulance and listen to a ton of action movie episodes. We're back this month with an action movie voted on by our members and it's sure to be a doozy. leave us a message at 412-407-7025 hang out with some cool listeners at https://discord.gg/DutFjx3cBD buy merch at www.teepublic.com/user/werewolfambulance the best place to reach us is at werewolfambulance@gmail.com we're on Reddit at r/werewolfambulance sorta on Twitter @werebulance sorta on Instagram @werewolfambulance www.werewolfambulance.com if you feel you really must lodge a complaint with us, please do it on Facebook at facebook.com/werewolfambulance because we are probably not gonna see that, ever. If you liked this, please leave us a review on Apple Podcasts or wherever you listen! It helps others find us and allows us to continue to grow. Intro song is by Alex Van Luvie Outro song is A. Wallis- "EMT" Seriously, we have the best listeners, hands down.
In this conversation, Henry Abbott discusses his transition from sports media to writing a book on injury prevention, "Ballistic: The New Science of Injury-Free Athletic Performance." Blending cutting-edge science with gripping storytelling, award-winning data journalist and competitive amateur athlete Henry Abbott reveals that we are on the cusp of a new era in sports medicine, built around the science of ballistic movements―leaping and landing―and the unique fingerprint of your body's physics. Abbott's inspiring narrative tells the story of sports scientist Dr. Marcus Elliott and the Peak Performance Project (P3), who use technology to study how athletes move and why they get hurt. Applying machine learning and lessons from biomechanics, medicine, and physiology, doctors at P3 can now detect elevated risk of an ACL tear or a pulled hamstring like an echocardiogram can see warning signs of a heart attack. Their data-driven findings are full of surprises. Your body's most important defense against knee and ankle injuries are the little-known muscles in the lower leg and hip area, which typical workouts rarely target. Similarly, the glutes―not the core―do the most to prevent back pain. Transformative benefits flow from training underappreciated kinds of athleticism like rotation, deceleration, and relaxation. Most of all, science shows that the best athletes don't avoid ballistics―they master them. Through riveting stories of elite athletes overcoming injuries and pushing themselves to the limit, Abbott presents an evidence-based case for intervening early to protect our bodies. And he suggests that we can all harness the science of ballistic movement not just to run fast or jump high but to move with joy and lead fulfilling athletic lives. You can buy Henry's book here: https://a.co/d/a2B0Bp4. Sponsors ASICS - Checkout the upcoming Novablast 5 and pre-order this amazing shoe at www.asics.com. Peregrune - I've been using Peregrune supplements, including their Runner Multivitamin and Runner Joint, everyday since 2023 and for good reason. They are NSF and third-party tested. They are also for runner, created by runners. Save 15% on your purchase at www.peregrune.com by using code "RAMBLING" at checkout. Boulderthon - Named among the Top 10 races in the U.S. by USA Today and one of the Best Fall Marathons by Runner's World, Boulderthon, is quickly becoming a must-run event for runners across the country. Whether you're up for a 5K, 10K, half-marathon, or the marathon, Boulderthon offers a race for every level of runner. Sign up today at Boulderthon.org and use code Rambling20 for $20 off the 13.1 or 26.2! See you in Boulder! Learn more about your ad choices. Visit megaphone.fm/adchoices
After putting his political capital on the line in GOP primaries, Abbott is close to enacting $10,000 scholarships for 100,000 students, as the bill passes the state House with votes to spare. Plus, New York Sen. Chuck Schumer blocks two of Donald Trump's nominees for federal prosecutor by withholding his "blue slip," but the president says he'll give Jay Clayton an interim appointment Learn more about your ad choices. Visit megaphone.fm/adchoices